Mass treatment with ivermectin: An underutilized public health strategy

Bulletin of the World Health Organization

Volumn 82, Issue 8, 2004, Pages 562-

  Speare, Rick ^a   Durrheim, David ^a  

^a JAMES COOK UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTIPARASITIC AGENT; DELTAMETHRIN; DIETHYLCARBAMAZINE; IVERMECTIN; MEBENDAZOLE;

HEALTH CARE; IVERMECTIN; PUBLIC HEALTH;

COMMUNITY CARE; DRUG INDUSTRY; EDITORIAL; FILARIASIS; HEALTH PROMOTION; HELMINTHIASIS; HUMAN; INFECTION CONTROL; NEMATODIASIS; NONHUMAN; ONCHOCERCIASIS; PARASITOSIS; PATENT; SCABIES; STRONGYLOIDIASIS; VETERINARY MEDICINE; WORLD HEALTH ORGANIZATION;

ANIMALS; HUMANS; IVERMECTIN; PARASITIC DISEASES; PUBLIC HEALTH PRACTICE; SCABIES; STRONGYLIDA INFECTIONS;

EID: 4243138114     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (10)

1. Collins K. Profitable gifts: a history of the Merck Mectivan donation program and its implications for international health. Perspectives in Biology and Medicine 2004;47:100-9.
2. Conway DJ, Lindo JF, Robinson RD, Bundy DAP. Towards effective control of Strongyloides stercoralis. Parasitology Today 1995;11:421-4.
3. Datry A, Hilmarsdottir I, Mayorga-Sagastume R, Lyagoubi M, Gaxotte P, Biligui S, et al. Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases. Transactions of the Royal Society of Tropical Medicine and Hygiene 1994;88:344-5.
4. Gann PH, Neva FA, Gam AA. A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. Journal of Infectious Diseases 1994;169:1076-9.
5. Toma H, Sato Y, Shiroma Y, Kobayashi J, Shimabukuro I, Takara M. Comparative studies on the efficacy of three anthelminthics on treatment of human strongyloidiasis in Okinawa, Japan. Southeast Asian Journal of Tropical Medicine and Public Health 2000;31:147-51.
6. Adenusi AA, Oke AO, Adenusi AO. Comparison of ivermectin and thiabendazole in the treatment of uncomplicated human Strongyloides stercoralis infection. African Journal of Biotechnology 2003;2:465-9.
7. Kipp W, Bamhuhiiga J, Rubaale T, Buttner DW. Adverse reactions to ivermectin treatment in Simulium naevei-transmitted onchocerciasis. American Journal of Tropical Medicine and Hygiene 2003;69:621-3.
8. Awadzi K. Clinical picture and outcome of serious adverse events in the treatment of onchocerciasis. Filaria Journal 2003;2 Suppl:S6. Available from: http://filariajournal.com/content/2/S1/S6
9. Gyapong JO, Chinbuah MA, Gyapong M. Inadvertent exposure of pregnant women to ivermectin and albendazole during mass drug administration for lymphatic filariasis. Tropical Medicine and International Health 2003;8:1093-101.
10. McCarthy JS, Garrow SC. Parasite elimination programs: at home and away. Medical Journal of Australia 2002;176:456-7.